| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1146/ANNUREV.NUTR.20.1.169 |
| P698 | PubMed publication ID | 10940331 |
| P2093 | author name string | Shelness GS | |
| Davidson NO | |||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | lipoprotein | Q28350 |
| P304 | page(s) | 169-193 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Annual Review of Nutrition | Q4769675 |
| P1476 | title | APOLIPOPROTEIN B: mRNA editing, lipoprotein assembly, and presecretory degradation | |
| P478 | volume | 20 |
| Q52604480 | A Drosophila microsomal triglyceride transfer protein homolog promotes the assembly and secretion of human apolipoprotein B. Implications for human and insect transport and metabolism. |
| Q31121956 | A W-test collapsing method for rare-variant association testing in exome sequencing data. |
| Q83229108 | A critical role of VMP1 in lipoprotein secretion |
| Q43948878 | A proteomic approach identifies proteins in hepatocytes that bind nascent apolipoprotein B. |
| Q40633609 | A role for palmitoylation in the quality control, assembly and secretion of apolipoprotein B |
| Q34770418 | AID and mismatch repair in antibody diversification |
| Q36845671 | AID-initiated purposeful mutations in immunoglobulin genes |
| Q34910421 | APOBEC‐1‐mediated RNA editing |
| Q28582103 | ARP-1/COUP-TF II determines hepatoma phenotype by acting as both a transcriptional repressor of microsomal triglyceride transfer protein and an inducer of CYP7A1 |
| Q49913361 | Activation of constitutive androstane receptor ameliorates renal ischemia-reperfusion induced liver and kidney injury |
| Q36175990 | Acute hypoxia induces hypertriglyceridemia by decreasing plasma triglyceride clearance in mice |
| Q40622275 | Amino acid sequences within the beta1 domain of human apolipoprotein B can mediate rapid intracellular degradation |
| Q45270105 | An apolipoprotein B antisense oligonucleotide lowers LDL cholesterol in hyperlipidemic mice without causing hepatic steatosis |
| Q35541914 | ApoB siRNA-induced liver steatosis is resistant to clearance by the loss of fatty acid transport protein 5 (Fatp5) |
| Q36836010 | ApoB100 is required for increased VLDL-triglyceride secretion by microsomal triglyceride transfer protein in ob/ob mice |
| Q98177468 | ApoB48 as an Efficient Regulator of Intestinal Lipid Transport |
| Q36667057 | Apobec-1 Complementation Factor (A1CF) Inhibits Epithelial-Mesenchymal Transition and Migration of Normal Rat Kidney Proximal Tubular Epithelial Cells |
| Q37746984 | Apolipoprotein B100 biogenesis: a complex array of intracellular mechanisms regulating folding, stability, and lipoprotein assembly |
| Q33858526 | Apolipoprotein B100 quality control and the regulation of hepatic very low density lipoprotein secretion. |
| Q28278173 | Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis |
| Q36536256 | Apolipoproteins A-I and B: biosynthesis, role in the development of atherosclerosis and targets for intervention against cardiovascular disease |
| Q40485371 | Apple procyanidins decrease cholesterol esterification and lipoprotein secretion in Caco-2/TC7 enterocytes |
| Q44317091 | Blocking microsomal triglyceride transfer protein interferes with apoB secretion without causing retention or stress in the ER. |
| Q24633130 | C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express both the type II transcript and apobec-1, the catalytic subunit of the apolipoprotein B mRNA-editing enzyme |
| Q47703480 | CD1d function is regulated by microsomal triglyceride transfer protein |
| Q39790745 | CFTR knockdown stimulates lipid synthesis and transport in intestinal Caco-2/15 cells |
| Q36251148 | Cardiomyocyte Regulation of Systemic Lipid Metabolism by the Apolipoprotein B-Containing Lipoproteins in Drosophila. |
| Q38046628 | Clinical pharmacological properties of mipomersen (Kynamro), a second generation antisense inhibitor of apolipoprotein B. |
| Q40236656 | Coordinate transcriptional repression of liver fatty acid-binding protein and microsomal triglyceride transfer protein blocks hepatic very low density lipoprotein secretion without hepatosteatosis |
| Q37285061 | Decreased expression of cholesterol 7alpha-hydroxylase and altered bile acid metabolism in Apobec-1-/- mice lead to increased gallstone susceptibility |
| Q34053069 | Deficiency in hepatic ATP-citrate lyase affects VLDL-triglyceride mobilization and liver fatty acid composition in mice |
| Q37738362 | Development of apolipoprotein B antisense molecules as a therapy for hyperlipidemia |
| Q37152284 | Dietary green tea extract lowers plasma and hepatic triglycerides and decreases the expression of sterol regulatory element-binding protein-1c mRNA and its responsive genes in fructose-fed, ovariectomized rats |
| Q44386370 | Dual action of neutral sphingomyelinase on rat hepatocytes: activation of cholesteryl ester metabolism and biliary cholesterol secretion and inhibition of VLDL secretion |
| Q35958491 | Effects of CETP inhibition on triglyceride-rich lipoprotein composition and apoB-48 metabolism |
| Q36619771 | Effects of pyrazole partial agonists on HCA(2) -mediated flushing and VLDL-triglyceride levels in mice |
| Q35614922 | Endoplasmic reticulum stress and lipid metabolism: mechanisms and therapeutic potential |
| Q28582707 | Epigallocatechin gallate increases the formation of cytosolic lipid droplets and decreases the secretion of apoB-100 VLDL |
| Q39214058 | FDA-Approved Oligonucleotide Therapies in 2017. |
| Q26828489 | Familial hypercholesterolemia: present and future management |
| Q28183795 | Familial hypobetalipoproteinemia: a review |
| Q37805344 | FoxO1 and hepatic lipid metabolism |
| Q37596560 | From sugar to fat: How the transcription factor XBP1 regulates hepatic lipogenesis |
| Q46953374 | Gene expression profiling in livers of mice after acute inhibition of beta-oxidation. |
| Q36677357 | Genetic Architectures of Quantitative Variation in RNA Editing Pathways |
| Q90408235 | Grasp55-/- mice display impaired fat absorption and resistance to high-fat diet-induced obesity |
| Q50898708 | Hepatic ABCA1 deficiency is associated with delayed apolipoprotein B secretory trafficking and augmented VLDL triglyceride secretion. |
| Q45927414 | Hepatic VLDL assembly is disturbed in a rat model of nonalcoholic fatty liver disease: is there a role for dietary coenzyme Q? |
| Q28593031 | Hepatic secretion of apoB-100 is impaired in hypobetalipoproteinemic mice with an apoB-38.9-specifying allele |
| Q43764679 | Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance |
| Q42009283 | Hepatic very-low-density lipoprotein and apolipoprotein B production are increased following in vivo induction of betaine-homocysteine S-methyltransferase |
| Q24337547 | Hepatitis C virus nonstructural proteins inhibit apolipoprotein B100 secretion |
| Q39380623 | Hepatitis C virus-apolipoprotein interactions: molecular mechanisms and clinical impact. |
| Q47917169 | Human MicroRNA-548p Decreases Hepatic Apolipoprotein B Secretion and Lipid Synthesis |
| Q35119646 | Hydrolytic nucleoside and nucleotide deamination, and genetic instability: a possible link between RNA-editing enzymes and cancer? |
| Q44525130 | Identification of lipoproteins of intestinal origin in human atherosclerotic plaque |
| Q43589186 | Increased production of apolipoprotein B-containing lipoproteins in the absence of hyperlipidemia in transgenic mice expressing cholesterol 7alpha-hydroxylase |
| Q27312336 | Induction of body weight loss through RNAi-knockdown of APOBEC1 gene expression in transgenic rabbits |
| Q40741210 | Influence of peroxisome proliferator-activated receptor alpha agonists on the intracellular turnover and secretion of apolipoprotein (Apo) B-100 and ApoB-48. |
| Q42032989 | Insect lipoprotein biogenesis depends on an amphipathic beta cluster in apolipophorin II/I and is stimulated by microsomal triglyceride transfer protein |
| Q38267212 | Insights from human congenital disorders of intestinal lipid metabolism |
| Q36532383 | Insulin suppression of apolipoprotein B in McArdle RH7777 cells involves increased sortilin 1 interaction and lysosomal targeting |
| Q39150236 | Insulin-dependent apolipoprotein B degradation is mediated by autophagy and involves class I and class III phosphatidylinositide 3-kinases |
| Q30586189 | Integrative analysis of proteomic and transcriptomic data for identification of pathways related to simvastatin-induced hepatotoxicity |
| Q37416809 | Interactions between α-tocopherol, polyunsaturated fatty acids, and lipoxygenases during embryogenesis |
| Q34985745 | Intersection of the unfolded protein response and hepatic lipid metabolism |
| Q45152786 | Intestinal fatty acid binding protein and microsomal triglyceride transfer protein polymorphisms in French-Canadian youth |
| Q27023275 | Intestinal triacylglycerol synthesis in fat absorption and systemic energy metabolism |
| Q47422948 | Kupffer cell products and interleukin 1beta directly promote VLDL secretion and apoB mRNA up-regulation in rodent hepatocytes |
| Q39703162 | Lipid synthesis and secretion in HepG2 cells is not affected by ACTH. |
| Q52591066 | Lipid transfer proteins in the assembly of apoB-containing lipoproteins. |
| Q34785828 | Lipid-dependent bidirectional traffic of apolipoprotein B in polarized enterocytes. |
| Q36748145 | Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs |
| Q45981719 | Localization, function and regulation of the two intestinal fatty acid-binding protein types. |
| Q44387529 | Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA. |
| Q34399523 | Mechanisms of hepatic very low-density lipoprotein overproduction in insulin resistance |
| Q47998188 | MicroRNA-101-2-5p targets the ApoB gene in the liver of chicken (Gallus Gallus). |
| Q28624200 | Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly |
| Q38229839 | Mipomersen is a promising therapy in the management of hypercholesterolemia: a meta-analysis of randomized controlled trials |
| Q36674717 | Molecular diversity and evolution of the large lipid transfer protein superfamily |
| Q35578251 | Molecular regulation, evolutionary, and functional adaptations associated with C to U editing of mammalian apolipoproteinB mRNA. |
| Q24598767 | Mouse and other rodent models of C to U RNA editing |
| Q51979748 | Mouse models as tools to explore cytidine-to-uridine RNA editing. |
| Q21245057 | Multiple functions of microsomal triglyceride transfer protein |
| Q28188677 | Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation of C to U RNA-editing activity |
| Q35897027 | NR2F1 disrupts synergistic activation of the MTTP gene transcription by HNF-4α and HNF-1α. |
| Q35115696 | Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference |
| Q28189260 | Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing. CUGBP2 modulates C to U editing of apolipoprotein B mRNA by interacting with apobec-1 and ACF, the apobec-1 complementation factor |
| Q36549516 | Nucleotide levels regulate germline proliferation through modulating GLP-1/Notch signaling in C. elegans. |
| Q51798503 | PI3-kinase activity modulates apo B available for hepatic VLDL production in apobec-1-/- mice. |
| Q38615339 | Paradoxical interplay of viral and cellular functions |
| Q46944888 | Phospholipid transfer activity of microsomal triacylglycerol transfer protein is sufficient for the assembly and secretion of apolipoprotein B lipoproteins |
| Q37347295 | Polymorphisms of microsomal triglyceride transfer protein in different hepatitis B virus-infected patients |
| Q36180569 | Prepartum body condition score and plane of nutrition affect the hepatic transcriptome during the transition period in grazing dairy cows |
| Q80113620 | Providing AID to p53 mutagenesis |
| Q37087690 | Reconstituting initial events during the assembly of apolipoprotein B-containing lipoproteins in a cell-free system. |
| Q92020813 | Regulation of Chylomicron Secretion: Focus on Post-Assembly Mechanisms |
| Q28507784 | Regulation of hepatic lipogenesis by the transcription factor XBP1 |
| Q37719350 | Regulation of hepatic lipogenesis by the zinc finger protein Zbtb20. |
| Q35546546 | Regulation of human apolipoprotein B gene expression at multiple levels. |
| Q34115234 | Regulation of immunoglobulin class-switch recombination: choreography of noncoding transcription, targeted DNA deamination, and long-range DNA repair |
| Q41888381 | Rescue of Mtp siRNA-induced hepatic steatosis by DGAT2 siRNA silencing |
| Q40470219 | Retina expresses microsomal triglyceride transfer protein: implications for age-related maculopathy. |
| Q36796856 | Retrotranslocation of prion proteins from the endoplasmic reticulum by preventing GPI signal transamidation |
| Q33402916 | Sensing of dietary lipids by enterocytes: a new role for SR-BI/CLA-1 |
| Q35058222 | Small, dense low-density lipoprotein: risk or myth? |
| Q24535846 | Somatic hypermutation of the AID transgene in B and non-B cells |
| Q37014938 | Structural and dynamic interfacial properties of the lipoprotein initiating domain of apolipoprotein B. |
| Q39972673 | The AAA-ATPase p97 facilitates degradation of apolipoprotein B by the ubiquitin-proteasome pathway |
| Q92321823 | The LipoGlo reporter system for sensitive and specific monitoring of atherogenic lipoproteins |
| Q92577413 | The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids |
| Q57842577 | The Translocation Apparatus of the Endoplasmic Reticulum |
| Q37144226 | The assembly of apoB-containing lipoproteins: a structural biology point of view |
| Q43946829 | The complex of the insect LDL receptor homolog, lipophorin receptor, LpR, and its lipoprotein ligand does not dissociate under endosomal conditions |
| Q92508188 | The crystal structure of human microsomal triglyceride transfer protein |
| Q40559953 | The hepatitis B virus X protein inhibits secretion of apolipoprotein B by enhancing the expression of N-acetylglucosaminyltransferase III. |
| Q38410893 | The pathophysiology of intestinal lipoprotein production. |
| Q44881213 | The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic le |
| Q47380672 | Therapeutic potential of mipomersen in the management of familial hypercholesterolaemia |
| Q36467350 | Trans-Golgi proteins participate in the control of lipid droplet and chylomicron formation |
| Q42440926 | Transcriptome response of enterocytes to dietary lipids: impact on cell architecture, signaling, and metabolism genes. |
| Q27022700 | Translational control mechanisms in metabolic regulation: critical role of RNA binding proteins, microRNAs, and cytoplasmic RNA granules |
| Q28564773 | Upregulation of apolipoprotein B secretion, but not lipid, by tumor necrosis factor-alpha in rat hepatocyte cultures in the absence of extracellular fatty acids |
| Q46897741 | Why does the gut choose apolipoprotein B48 but not B100 for chylomicron formation? |
| Q104073438 | XBP1 links the 12-hour clock to NAFLD and regulation of membrane fluidity and lipid homeostasis |
| Q81321829 | [Digestive and absorptive processes of lipids] |
Search more.